Strides Pharma Science reports standalone net profit of Rs 47.00 crore in the September 2019 quarter

Sales rise 25.70% to Rs 425.41 crore

Net profit of Strides Pharma Science reported to Rs 47.00 crore in the quarter ended September 2019 as against net loss of Rs 14.30 crore during the previous quarter ended September 2018. Sales rose 25.70% to Rs 425.41 crore in the quarter ended September 2019 as against Rs 338.43 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales425.41338.43 26 OPM %14.95-1.00 -PBDT80.915.62 1340 PBT58.22-15.61 LP NP47.00-14.30 LP

Powered by Capital Market - Live News